Tetracaine HCl Nasal Solution, 4%, 240 mL per bottle, Multiple Dose Container for Intranasal Use,...

FDA Recall #D-0447-2022 — Class II — December 6, 2021

Recall #D-0447-2022 Date: December 6, 2021 Classification: Class II Status: Terminated

Product Description

Tetracaine HCl Nasal Solution, 4%, 240 mL per bottle, Multiple Dose Container for Intranasal Use, Edge Pharma, LLC, 856 Hercules Dr., Colchester, VT, 05446, NDC 05446-1195-03, packaged in bottles.

Reason for Recall

CGMP Deviations

Recalling Firm

Edge Pharma, LLC — Colchester, VT

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

114 bottles

Distribution

nationwide

Code Information

06-2021-08@5 12-05-2021, 07-2021-07@7 01-03-2022, 07-2021-27@10 01-23-2022 & 10-2021-06@12 04-04-2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated